1 false false false false false false false false false false true false false false false false false No description of principal activity 2023-04-01 Sage Accounts Production Advanced 2023 - FRS102_2023 2,974 1,444 383 1,827 1,147 1,530 xbrli:pure xbrli:shares iso4217:GBP 09397535 2023-04-01 2024-03-31 09397535 2024-03-31 09397535 2023-03-31 09397535 2022-04-01 2023-03-31 09397535 2023-03-31 09397535 2022-03-31 09397535 bus:Director1 2023-04-01 2024-03-31 09397535 core:WithinOneYear 2024-03-31 09397535 core:WithinOneYear 2023-03-31 09397535 core:ShareCapital 2024-03-31 09397535 core:ShareCapital 2023-03-31 09397535 core:RetainedEarningsAccumulatedLosses 2024-03-31 09397535 core:RetainedEarningsAccumulatedLosses 2023-03-31 09397535 bus:Director1 2023-03-31 09397535 bus:Director1 2024-03-31 09397535 bus:Director1 2022-03-31 09397535 bus:Director1 2023-03-31 09397535 bus:Director1 2022-04-01 2023-03-31 09397535 bus:SmallEntities 2023-04-01 2024-03-31 09397535 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 09397535 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 09397535 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 09397535 bus:FullAccounts 2023-04-01 2024-03-31 09397535 core:OfficeEquipment 2023-04-01 2024-03-31 09397535 core:OfficeEquipment 2024-03-31 09397535 core:OfficeEquipment 2023-03-31
COMPANY REGISTRATION NUMBER: 09397535
Capsey Clinical Communications Limited
Filleted Unaudited Financial Statements
31 March 2024
Capsey Clinical Communications Limited
Statement of Financial Position
31 March 2024
2024
2023
Note
£
£
£
Fixed assets
Tangible assets
5
1,147
1,530
Current assets
Debtors
6
40,219
44,930
Investments
7
72,185
67,263
Cash at bank and in hand
223,967
171,169
---------
---------
336,371
283,362
Creditors: amounts falling due within one year
8
27,899
27,191
---------
---------
Net current assets
308,472
256,171
---------
---------
Total assets less current liabilities
309,619
257,701
---------
---------
Net assets
309,619
257,701
---------
---------
Capital and reserves
Called up share capital
1
1
Profit and loss account
309,618
257,700
---------
---------
Shareholders funds
309,619
257,701
---------
---------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 29 October 2024 , and are signed on behalf of the board by:
Dr L Capsey
Director
Company registration number: 09397535
Capsey Clinical Communications Limited
Notes to the Financial Statements
Year ended 31 March 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 5 Minton Place, Victoria Road, Bicester, Oxon, OX26 6QB.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax.
Income tax
The taxation expense represents the amount of current recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Office Equipment
-
25% reducing balance
4. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2023: 1 ).
5. Tangible assets
Equipment
Total
£
£
Cost
At 1 April 2023 and 31 March 2024
2,974
2,974
-------
-------
Depreciation
At 1 April 2023
1,444
1,444
Charge for the year
383
383
-------
-------
At 31 March 2024
1,827
1,827
-------
-------
Carrying amount
At 31 March 2024
1,147
1,147
-------
-------
At 31 March 2023
1,530
1,530
-------
-------
6. Debtors
2024
2023
£
£
Trade debtors
27,792
36,845
Other debtors
12,427
8,085
--------
--------
40,219
44,930
--------
--------
7. Investments
2024
2023
£
£
Other investments
72,185
67,263
--------
--------
8. Creditors: amounts falling due within one year
2024
2023
£
£
Corporation tax
25,898
20,092
Social security and other taxes
533
933
Other creditors
1,468
6,166
--------
--------
27,899
27,191
--------
--------
9. Director's advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2024
Balance brought forward
Advances/ (credits) to the director
Amounts repaid
Balance outstanding
£
£
£
£
Dr L Capsey
( 4,916)
51,830
( 47,010)
( 96)
-------
--------
--------
----
2023
Balance brought forward
Advances/ (credits) to the director
Amounts repaid
Balance outstanding
£
£
£
£
Dr L Capsey
( 1,141)
43,900
( 47,675)
( 4,916)
-------
--------
--------
-------